RxSight, Inc. RXST
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.31% | -18.48% | -18.91% | -14.09% | -3.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.31% | -18.48% | -18.91% | -14.09% | -3.58% |
| Cost of Revenue | -7.01% | -22.69% | -35.72% | -39.44% | -20.59% |
| Gross Profit | 2.76% | -17.05% | -12.24% | -3.94% | 3.88% |
| SG&A Expenses | 4.98% | 11.24% | -2.09% | 6.78% | 19.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.27% | 0.32% | -10.03% | -4.54% | 10.23% |
| Operating Income | 1.66% | -67.03% | -31.40% | -32.00% | -68.04% |
| Income Before Tax | -2.17% | -94.30% | -54.35% | -55.04% | -93.86% |
| Income Tax Expenses | 175.00% | -66.67% | -58.33% | -23.08% | 100.00% |
| Earnings from Continuing Operations | -2.64% | -93.94% | -54.13% | -54.88% | -93.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.64% | -93.94% | -54.13% | -54.88% | -93.88% |
| EBIT | 1.66% | -67.03% | -31.40% | -32.00% | -68.04% |
| EBITDA | 3.38% | -71.70% | -29.25% | -39.92% | -75.75% |
| EPS Basic | -0.80% | -90.16% | -51.12% | -50.41% | -82.99% |
| Normalized Basic EPS | -0.33% | -90.48% | -51.20% | -50.50% | -83.05% |
| EPS Diluted | -0.80% | -90.16% | -51.12% | -50.41% | -82.99% |
| Normalized Diluted EPS | -0.33% | -90.48% | -51.20% | -50.50% | -83.05% |
| Average Basic Shares Outstanding | 1.83% | 1.97% | 2.03% | 2.96% | 5.95% |
| Average Diluted Shares Outstanding | 1.83% | 1.97% | 2.03% | 2.96% | 5.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |